Calcium ionophore A23187 specifically decreases the secretion of β-secretase cleaved amyloid precursor protein during apoptosis in primary rat cortical cultures

Alzheimer's disease (AD) is characterized by the degeneration and loss of neurons, intracellular neurofibrillary tangles and the accumulation of extracellular senile plaques consisting mainly of β‐amyloid (Aβ). Aβ is generated from the amyloid precursor protein (APP) by sequential β‐ and γ‐secr...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroscience research Vol. 63; no. 5; pp. 429 - 437
Main Authors Sennvik, Kristina, Benedikz, Eirikur, Fastbom, Johan, Sundström, Erik, Winblad, Bengt, Ankarcrona, Maria
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 01.03.2001
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer's disease (AD) is characterized by the degeneration and loss of neurons, intracellular neurofibrillary tangles and the accumulation of extracellular senile plaques consisting mainly of β‐amyloid (Aβ). Aβ is generated from the amyloid precursor protein (APP) by sequential β‐ and γ‐secretase cleavage. Alternatively, APP may be cleaved within the Aβ region by α‐secretase, preventing Aβ formation. Here we investigated APP processing and secretion in primary neurons, using either colchicine or the calcium ionophore A23187 to induce apoptosis. Cell viability was determined by MTT measurements and apoptosis was further confirmed by annexin V and propidium iodide staining. We found that exposure to A23187 significantly decreased the secretion of soluble β‐secretase cleaved APP (β‐sAPP) in a caspase‐dependent manner, although the secretion of total soluble APP βsAPP) did not change. In addition, caspase inhibition restored cell viability to control levels. Exposure to colchicine did not change the amount of either secreted β‐sAPP or total sAPP and caspase inhibition was only partially able to restore cell viability. We conclude that calcium homeostasis is an important apoptotic effector specifically affecting the β‐secretase cleavage of APP. J. Neurosci. Res. 63:429–437, 2001. © 2001 Wiley‐Liss, Inc.
Bibliography:Swedish Alzheimer Disease Foundation
Karolinska Institute Foundation for Geriatric Research
Gamla Tjänarinnor Foundation
Swedish Medical Council
ark:/67375/WNG-74QP9BQ6-6
istex:8E33858B540059F8AD8A5413D59D37A3EF53E034
ArticleID:JNR1038
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0360-4012
1097-4547
DOI:10.1002/1097-4547(20010301)63:5<429::AID-JNR1038>3.0.CO;2-U